MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever

Clinical Genetics

Volumn 71, Issue 5, 2007, Pages 458-467

  Giaglis, S ^a   Papadopoulos, V ^a   Kambas, K ^a   Doumas, M ^a   Tsironidou, V ^a   Rafail, S ^a   Kartalis, G ^a   Speletas, M ^b   Ritis, Konstantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

FMF; Haplotypes; MEFV; SNPs

Indexed keywords

GENE PRODUCT; GENOMIC DNA; PROTEIN MEFV; RIBONUCLEASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; ENZYME DEGRADATION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GREECE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYLOGENY; POPULATION GENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

COHORT STUDIES; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; GENETICS, POPULATION; GENOTYPE; GREECE; HAPLOTYPES; HUMANS; MUTATION; PHENOTYPE;

EID: 34248351562     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00789.x     Document Type: Article

References (39)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967: 43: 227-253.
2. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 2000: 14: 477-498.
3. Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991: 34: 973-977.
4. McDermott MF, Aksentijevich I. The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2002: 2: 511-516.
5. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997: 17: 25-31.
6. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997: 90: 797-807.
7. Touitou I, Lesage S, McDermott M et al. Infevers: An evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004: 24: 194-198.
8. Centola M, Wood G, Frucht DM et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000: 95: 3223-3231.
9. Tidow N, Chen X, Muller C et al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood 2000: 95: 1451-1455.
10. Martinon F, Hofmann K, Tschopp J. The pyrin domain: A possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 2001: 11: R118-R120.
11. Gumucio DL, Diaz A, Schaner P et al. Fire and ICE: The role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002: 20: S45-S53.
12. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003: 302: 575-580.
13. Chae JJ, Komarow HD, Cheng J et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003: 11: 591-604.
14. Deltas CC, Mean R, Rossou E et al. Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus. Genet Test 2002: 6: 15-21.
15. La Regina M, Nucera G, Diaco M et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2003: 11: 50-56.
16. Aldea A, Calafell F, Arostegui JI et al. The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination "hotspot" at the MEFV locus. Hum Mutat 2004: 23: 399-406.
17. Ozen S, Balci B, Ozkara S et al. Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: speculations remain? Clin Exp Rheumatol 2002: 20: S57-S58.
18. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001: 9: 473-483.
19. Kastner DL. Familial Mediterranean fever: The genetics of inflammation. Hosp Pract (Off Ed) 1998: 33: 131-146.
20. Schaner P, Richards N, Wadhwa A et al. Episodic evolution of pyrin in primates: Human mutations recapitulate ancestral amino acid states. Nat Genet 2001: 27: 318-321.
21. Konstantopoulos K, Kanta A, Deltas C et al. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 2003: 62: 479-481.
22. Ritis K, Giaglis S, Spathari N et al. Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients. Ann Rheum Dis 2004: 63: 438-443.
23. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997: 40: 1879-1885.
24. Mor A, Shinar Y, Zaks N et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005: 35: 57-64.
25. Goldrick MM, Kimball GR, Liu Q, Martin LA, Sommer SS, Tseng JY. NIRCA: A rapid robust method for screening for unknown point mutations. Biotechniques 1996: 21: 106-112.
26. Papin S, Cazeneuve C, Duquesnoy P, Jeru I, Sahali D, Amselem S. The tumor necrosis factor alpha-dependent activation of the human mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBP beta and NF kappaB p65. J Biol Chem 2003: 278: 48839-48847.
27. Schneider S, Roessli D, Excoffier L. Arlequin ver. 2.000: A software for population genetics data analysis. Geneva, Switzerland: Genetics and Biometry Laboratory, University of Geneva, 2000.
28. Felsenstein J. PHYLIP -phylogeny inference package (version 3.2). Cladistics 1989: 5: 164-166.
29. Rozas J, Sanchez-Delbarrio JC, Messeguer X, Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003: 19: 2496-2497.
30. Giaglis S, Mimidis K, Papadopoulos V et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: Evidence for a potential disease-modifying effect? Dig Dis Sci 2006: 51: 687-692.
31. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002: 10: 145-159.
32. Aksentijevich I, Torosyan Y, Samuels J et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999: 64: 949-962.
33. Yilmaz E, Osen S, Balci B et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001: 9: 553-555.
34. Ben-Chetrit E, Urieli-Shoval S, Calko S, Abeliovich D, Matzner Y. Molecular diagnosis of FMF: Lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol 2002: 20: S25-S29.
35. Zaks N, Shinar Y, Padeh S et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Med Assoc J 2003: 5: 585-588.
36. Tunca M, Akar S, Onen F et al. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine (Baltimore) 2005: 84: 1-11.
37. Sarkisian T, Ajrapetyan H, Shahsuvaryan G. Molecular study of FMF patients in Armenia. Curr Drug Targets Inflamm Allergy 2005: 4: 113-116.
38. Majeed HA, El-Khateeb M, El-Shanti H, Rabaiha ZA, Tayeh M, Najib D. The spectrum of familial Mediterranean fever gene mutations in Arabs: Report of a large series. Semin Arthritis Rheum 2005: 34: 813-818.
39. Medlej-Hashim M, Serre JL, Corbani S et al. Familial Mediterranean fever (FMF) in Lebanon and Jordan: A population genetics study and report of three novel mutations. Eur J Med Genet 2005: 48: 412-420.